The store will not work correctly when cookies are disabled.
We are currently experiencing a delay in order processing for some digital products. Our team is actively working to resolve this issue. To avoid placing duplicate orders, please do not refresh or move away from the payment screen during checkout. If your order still shows a status of 'Processing' after 24 - 48 hours, please contact customer support.
We are currently experiencing a delay in order processing for some digital products. Our team is actively working to resolve this issue. To avoid placing duplicate orders, please do not refresh or move away from the payment screen during checkout. If your order still shows a status of 'Processing' after 24 - 48 hours, please contact customer support.
Alert
We are currently experiencing a delay in order processing for some digital products. Our team is actively working to resolve this issue. To avoid placing duplicate orders, please do not refresh or move away from the payment screen during checkout. If your order still shows a status of 'Processing' after 24 - 48 hours, please contact customer support.
Cardiac rhythm disorders are common, with atrial fibrillation (AF) being the most common form of arrhythmia. The prevalence of AF in the United States (US) is estimated to rise from ˜5.2 million in 2010 to 12.1 million in 2030. Data from a health insurance claims database covering 5% of the US found the incidence of AF was estimated at 1.2 million new cases in 2010 and projected it to increase to 2.6 million new cases in 2030. The lifetime risk of AF in the US is about ˜1 in 3 in Whites and ˜1 in 5 in Blacks. Even with current guideline-based management, AF patients have stroke, acute coronary syndrome, heart failure, and cardiovascular death at a rate of approximately 5% of patients per year, and 35 to 50% of patients with AF who receive adequate anticoagulation either receive inpatient therapy or die within 5 years. The goal of this webinar series is to improve outcomes for patients with atrial fibrillation.